This content is restricted.
Brief
Summary:
The Competition Board of Turkey has concluded its preliminary inquiries into allegations of violations of Article 4 of the Act no 4054 on the Protection of Competition by medical devices sector undertakings. Following discussions and observations, the Board deemed the findings significant and sufficient to launch investigations against Bu00c4u00b1u00c3u00a7akcu00c4u00b1lar Tu00c4u00b1bbi Cihazlar Sanayi ve Ticaret Au00c5u017e, Gazi Kimya Sanayi ve Ticaret Au00c5u015e, and Rectus Medikal u00c3u0153ru00c3u00bcnler ve Sau00c4u0178lu00c4u00b1k Hizmetleri Sanayi ve Ticaret Limited u00c5u017eirketi. The investigation decisions are publicly announced, indicating that the undertakings under investigation have not been found to have violated the Act or faced sanctions at this stage.
Highlights content goes here...
This content is restricted.
